Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "716.35", "chg": 69.85, "chgp": "10.8%", "dir": 1, "prev_price": "646.50", "mcapval": "1,434.83 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "Apr 29", "curr_time": "", "bse_nse_vol": "24.34 lacs", "exc_status": "Active", "traded_date": "Apr 29, 2026", "traded_date_str": "2026 04 29", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 710.9", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-hits-new-52-week-high-at-rs7109-3968002", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_priceRelatedfactors_3968002.png", "date": "2026-04-29 10:10:20", "description": "With a decisive surge to Rs 710.9 on 29 Apr 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This rally comes amid a backdrop of strong technical signals and sustained gains over the past three sessions, underscoring the stock's robust upward trajectory." }, { "title": "Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3963481", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_valuationdot_3963481.png", "date": "2026-04-27 08:00:14", "description": "Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance in the Pharmaceuticals & Biotechnology sector. This change is underpinned by improved price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, despite a modest decline in its share price on 27 Apr 2026." }, { "title": "Lincoln Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-3954897", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_technicaldot_3954897.png", "date": "2026-04-21 08:01:28", "description": "Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The stock’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and technical strength, positioning it favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3953036", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_mojoScore_3953036.png", "date": "2026-04-19 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Gains 1.82%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-gains-182-3-key-factors-driving-the-week-3952805", "imagepath": "", "date": "2026-04-19 10:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Apr:</strong> Stock edged up slightly to Rs.576.35 despite Sensex decline</p>\n <p><strong>15 Apr:</strong> Strong rally of 2.85% to Rs.592.80 amid Sensex surge</p>\n <p><strong>16 Apr:</strong> Technical and valuation upgrades announced, stock steady at Rs.592.40</p>\n <p><strong>17 Apr:</strong> Mild pullback to Rs.586.60 amid mixed technical signals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.576.10</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</di..." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3949999", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_technicaldot_3949999.png", "date": "2026-04-17 08:00:44", "description": "Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of April 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveal a complex picture of the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-shows-bullish-momentum-amid-technical-upgrades-3948122", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_technicaldot_3948122.png", "date": "2026-04-16 08:01:33", "description": "Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Sell to Hold. The stock’s recent performance, combined with positive signals from MACD, Bollinger Bands, and moving averages, suggests a strengthening trend that investors should closely monitor." }, { "title": "Lincoln Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3947996", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_valuationdot_3947996.png", "date": "2026-04-16 08:00:21", "description": "Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, supported by robust price-to-earnings and price-to-book value metrics. This re-rating comes alongside impressive stock returns that have outpaced the broader Sensex over multiple time frames, signalling renewed investor interest in this micro-cap pharmaceutical player." }, { "title": "Lincoln Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3938401", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_valuationdot_3938401.png", "date": "2026-04-09 08:00:21", "description": "Lincoln Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by a significant improvement in its price-to-earnings and price-to-book value ratios. This change comes amid a mixed performance in the Pharmaceuticals & Biotechnology sector, with Lincoln’s valuation now standing out favourably against its peers." } ], "total": 969, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A", "datetime": "16-Apr-2026", "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Lincoln Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230GJ1995PLC024288</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: TRUSHA SHAH <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: TRUSHASHAH@LINCOLNPHARMA.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: DARSHIT SHAH <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: DARSHIT@LINCOLNPHARMA.COM</div> </div> <div> <br/> Date: 16/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "06-Apr-2026", "details": "Pursuant to Provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 We hereby submit the confirmation Certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended March 31 2026.", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "25-Mar-2026", "details": "Intimation of Closure of Trading Window.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

13 Apr: Stock edged up slightly to Rs.576.35 despite Sensex decline

15 Apr: Strong rally of 2.85% to Rs.592.80 amid Sensex surge

16 Apr: Technical and valuation upgrades announced, stock steady at Rs.592.40

17 Apr: Mild pullback to Rs.586.60 amid mixed technical signals

Week Open

Rs.576.10

Week CloseRead full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-17 08:00:44

Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of April 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveal a complex picture of the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Read full news article

Lincoln Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-04-16 08:01:33

Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Sell to Hold. The stock’s recent performance, combined with positive signals from MACD, Bollinger Bands, and moving averages, suggests a strengthening trend that investors should closely monitor.

Read full news article

Lincoln Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-04-16 08:00:21

Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, supported by robust price-to-earnings and price-to-book value metrics. This re-rating comes alongside impressive stock returns that have outpaced the broader Sensex over multiple time frames, signalling renewed investor interest in this micro-cap pharmaceutical player.

Read full news article

Lincoln Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-04-09 08:00:21

Lincoln Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by a significant improvement in its price-to-earnings and price-to-book value ratios. This change comes amid a mixed performance in the Pharmaceuticals & Biotechnology sector, with Lincoln’s valuation now standing out favourably against its peers.

Read full news article

Sr. No.	Particulars	Details
1	Name of Company	Lincoln Pharmaceuticals Ltd
2	CIN NO.	L24230GJ1995PLC024288
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	0.00
4	Highest Credit Rating during the previous FY	NA
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	Not Applicable
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE